These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1779984)

  • 21. Structural diversity in the 45-kilodalton merozoite surface antigen of Plasmodium falciparum.
    Smythe JA; Peterson MG; Coppel RL; Saul AJ; Kemp DJ; Anders RF
    Mol Biochem Parasitol; 1990 Mar; 39(2):227-34. PubMed ID: 2181307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Two MSA 2 peptides that bind to human red blood cells are relevant to Plasmodium falciparum merozoite invasion.
    Ocampo M; Urquiza M; Guzmán F; Rodriguez LE; Suarez J; Curtidor H; Rosas J; Diaz M; Patarroyo ME
    J Pept Res; 2000 Mar; 55(3):216-23. PubMed ID: 10727103
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasmodium falciparum: extensive polymorphism in merozoite surface antigen 2 alleles in an area with endemic malaria in Papua New Guinea.
    Felger I; Tavul L; Kabintik S; Marshall V; Genton B; Alpers M; Beck HP
    Exp Parasitol; 1994 Sep; 79(2):106-16. PubMed ID: 7914494
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peptide vaccines derived from a malarial surface antigen: effects of dose and adjuvants on immunogenicity.
    Jones GL; Spencer L; Lord R; Mollard R; Pye D; Saul A
    Immunol Lett; 1990 Jul; 24(4):253-60. PubMed ID: 1697281
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenicity of a hybrid Plasmodium falciparum malaria antigen.
    Lockyer MJ; Cooper H; Tite J; Rowan W; Crowe JS
    Parasitology; 1993 Jun; 106 ( Pt 5)():451-7. PubMed ID: 8341580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Plasmodium falciparum: an epitope within a highly conserved region of the 47-kDa amino-terminal domain of the serine repeat antigen is a target of parasite-inhibitory antibodies.
    Fox BA; Xing-Li P; Suzue K; Horii T; Bzik DJ
    Exp Parasitol; 1997 Feb; 85(2):121-34. PubMed ID: 9030663
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fine specificity of immune responses to epitopic sequences in synthetic peptides containing B and T epitopes from the conserved Plasmodium falciparum blood-stage antigens.
    Chatterjee S; Sharma P; Kumar S; Chauhan VS
    Vaccine; 1995; 13(15):1474-81. PubMed ID: 8578829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Polymorphism of a high molecular weight schizont antigen of the human malaria parasite Plasmodium falciparum.
    McBride JS; Newbold CI; Anand R
    J Exp Med; 1985 Jan; 161(1):160-80. PubMed ID: 2578540
    [TBL] [Abstract][Full Text] [Related]  

  • 29. High antibody responses in rabbits immunized with influenza virus ISCOMs containing a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA.
    Sjölander A; Lövgren K; Ståhl S; Aslund L; Hansson M; Nygren PA; Larsson M; Hagstedt M; Wåhlin B; Berzins K
    Vaccine; 1991 Jun; 9(6):443-50. PubMed ID: 1887676
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Plasmodium falciparum: further characterization of a functionally active region of the merozoite invasion ligand EBA-175.
    Sim BK; Carter JM; Deal CD; Holland C; Haynes JD; Gross M
    Exp Parasitol; 1994 May; 78(3):259-68. PubMed ID: 7512929
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antibodies elicited by a virosomally formulated Plasmodium falciparum serine repeat antigen-5 derived peptide detect the processed 47 kDa fragment both in sporozoites and merozoites.
    Okitsu SL; Boato F; Mueller MS; Li DB; Vogel D; Westerfeld N; Zurbriggen R; Robinson JA; Pluschke G
    Peptides; 2007 Oct; 28(10):2051-60. PubMed ID: 17875342
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human immune response in Plasmodium falciparum malaria. Synthetic peptides corresponding to known epitopes of the Pf155/RESA antigen induce production of parasite-specific antibodies in vitro.
    Chougnet C; Troye-Blomberg M; Deloron P; Kabilan L; Lepers JP; Savel J; Perlmann P
    J Immunol; 1991 Oct; 147(7):2295-301. PubMed ID: 1717554
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lipopeptide immunization without adjuvant induces potent and long-lasting B, T helper, and cytotoxic T lymphocyte responses against a malaria liver stage antigen in mice and chimpanzees.
    BenMohamed L; Gras-Masse H; Tartar A; Daubersies P; Brahimi K; Bossus M; Thomas A; Druilhe P
    Eur J Immunol; 1997 May; 27(5):1242-53. PubMed ID: 9174617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Immunogenicity of recombinant Plasmodium falciparum SERA proteins in rodents.
    Barr PJ; Inselburg J; Green KM; Kansopon J; Hahm BK; Gibson HL; Lee-Ng CT; Bzik DJ; Li WB; Bathurst IC
    Mol Biochem Parasitol; 1991 Mar; 45(1):159-70. PubMed ID: 2052035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure and Characterisation of a Key Epitope in the Conserved C-Terminal Domain of the Malaria Vaccine Candidate MSP2.
    Seow J; Morales RA; MacRaild CA; Krishnarjuna B; McGowan S; Dingjan T; Jaipuria G; Rouet R; Wilde KL; Atreya HS; Richards JS; Anders RF; Christ D; Drinkwater N; Norton RS
    J Mol Biol; 2017 Mar; 429(6):836-846. PubMed ID: 28189425
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and efficacy trials in Aotus nancymai monkeys with model compounds representing parts of a 75-kD merozoite surface antigen of Plasmodium falciparum.
    Sharma P; Ruebush TK; Campbell GH; Richman SJ; Wilkins PP; Broderson JR; Ardeshir F; Gross M; Silverman C; Skinner JC
    Am J Trop Med Hyg; 1992 Jun; 46(6):691-707. PubMed ID: 1621894
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety, immunogenicity, and pilot efficacy of Plasmodium falciparum sporozoite and asexual blood-stage combination vaccine in Swiss adults.
    Sturchler D; Berger R; Rudin C; Just M; Saul A; Rzepczyk C; Brown G; Anders R; Coppel R; Woodrow G
    Am J Trop Med Hyg; 1995 Oct; 53(4):423-31. PubMed ID: 7485698
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differences in epitope recognition, isotype and titer of antisera to Plasmodium falciparum merozoite surface protein 4 raised by different modes of DNA or protein immunization.
    Wang L; Menting JG; Black CG; Stowers A; Kaslow DC; Hoffman SL; Coppel RL
    Vaccine; 2000 Nov; 19(7-8):816-24. PubMed ID: 11115704
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.
    Lougovskoi AA; Okoyeh NJ; Chauhan VS
    Vaccine; 1999 Dec; 18(9-10):920-30. PubMed ID: 10580206
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibodies to sequences in a non-repeat region of Plasmodium falciparum antigen Pf155/RESA inhibit either cytoadherence or parasite growth in vitro.
    Siddique AB; Ahlborg N; Wåhlin Flyg B; Perlmann P; Berzins K
    Parasitology; 1998 Sep; 117 ( Pt 3)():209-16. PubMed ID: 9774784
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.